Vanguard Capital Management’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
Vanguard Capital Management's TPST Position: Q3 2026 in Review
Vanguard Capital Management held its Tempest Therapeutics (TPST) position steady in Q3 2026 at 233,888 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3791.
Vanguard Capital Management first reported a position in TPST in Q1 2026 and has held it in 3 quarters since. The position peaked at $384K in Q1 2026. 24 funds tracked by Wall St. Rank hold TPST as of Q3 2026.
- Vanguard Capital Management held 233,888 shares of Tempest Therapeutics worth $195K as of Q3 2026.
- Vanguard Capital Management left its Tempest Therapeutics share count unchanged in Q3 2026.
- Tempest Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3791 holding.
- Vanguard Capital Management first reported a position in Tempest Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Tempest Therapeutics position peaked at $384K in Q1 2026.
- 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.